BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24706848)

  • 21. miR-199a-5p Relieves Obstructive Sleep Apnea Syndrome-Related Hypertension by Targeting HIF-1
    Guo C; Zhang M; Su W; Xu M; Zhao S
    J Immunol Res; 2022; 2022():7236647. PubMed ID: 35935584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metastasis Suppressors NME1 and NME2 Promote Dynamin 2 Oligomerization and Regulate Tumor Cell Endocytosis, Motility, and Metastasis.
    Khan I; Gril B; Steeg PS
    Cancer Res; 2019 Sep; 79(18):4689-4702. PubMed ID: 31311812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-199a Downregulation as a Driver of the NOX4/HIF-1α/VEGF-A Pathway in Thyroid and Orbital Adipose Tissues from Graves' Patients.
    Craps J; Joris V; Baldeschi L; Daumerie C; Camboni A; Buemi A; Lengelé B; Behets C; Boschi A; Mourad M; Many MC; Dessy C
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutual Regulation of MiR-199a-5p and HIF-1α Modulates the Warburg Effect in Hepatocellular Carcinoma.
    Li B; He L; Zuo D; He W; Wang Y; Zhang Y; Liu W; Yuan Y
    J Cancer; 2017; 8(6):940-949. PubMed ID: 28529605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIF-1α/Ascl2/miR-200b regulatory feedback circuit modulated the epithelial-mesenchymal transition (EMT) in colorectal cancer cells.
    Shang Y; Chen H; Ye J; Wei X; Liu S; Wang R
    Exp Cell Res; 2017 Nov; 360(2):243-256. PubMed ID: 28899657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of miR-199a-5p promotes prostate adeno-carcinoma progression through loss of its inhibition of HIF-1α.
    Zhong J; Huang R; Su Z; Zhang M; Xu M; Gong J; Chen N; Zeng H; Chen X; Zhou Q
    Oncotarget; 2017 Oct; 8(48):83523-83538. PubMed ID: 29137361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The intragenic microRNA
    Chen X; Gao YQ; Zheng YY; Wang W; Wang P; Liang J; Zhao W; Tao T; Sun J; Wei L; Li Y; Zhou Y; Gan Z; Zhang X; Chen HQ; Zhu MS
    J Biol Chem; 2020 Jun; 295(26):8656-8667. PubMed ID: 32354746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulation of TIMP2 by HIF-1α/miR-210/HIF-3α regulatory feedback circuit enhances cancer metastasis in hepatocellular carcinoma.
    Kai AK; Chan LK; Lo RC; Lee JM; Wong CC; Wong JC; Ng IO
    Hepatology; 2016 Aug; 64(2):473-87. PubMed ID: 27018975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxia-Inducible Factor-1α (HIF-1α) Promotes Hypoxia-Induced Invasion and Metastasis in Ovarian Cancer by Targeting Matrix Metallopeptidase 13 (MMP13).
    Zhang H; Yang Q; Lian X; Jiang P; Cui J
    Med Sci Monit; 2019 Sep; 25():7202-7208. PubMed ID: 31587013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lentivirus-mediated overexpression of microRNA-199a inhibits cell proliferation of human hepatocellular carcinoma.
    Jia XQ; Cheng HQ; Qian X; Bian CX; Shi ZM; Zhang JP; Jiang BH; Feng ZQ
    Cell Biochem Biophys; 2012 Jan; 62(1):237-44. PubMed ID: 21847633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA SNHG12 promotes vascular smooth muscle cell proliferation and migration via regulating miR-199a-5p/HIF-1α.
    Sun Y; Zhao JT; Chi BJ; Wang KF
    Cell Biol Int; 2020 Aug; 44(8):1714-1726. PubMed ID: 32339345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.
    Cheng W; Liu T; Wan X; Gao Y; Wang H
    FEBS J; 2012 Jun; 279(11):2047-59. PubMed ID: 22498306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inactivation of von Hippel-Lindau increases ovarian cancer cell aggressiveness through the HIF1α/miR-210/VMP1 signaling pathway.
    Liu T; Zhao L; Chen W; Li Z; Hou H; Ding L; Li X
    Int J Mol Med; 2014 May; 33(5):1236-42. PubMed ID: 24549370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia induces the overexpression of microRNA-21 in pancreatic cancer cells.
    Mace TA; Collins AL; Wojcik SE; Croce CM; Lesinski GB; Bloomston M
    J Surg Res; 2013 Oct; 184(2):855-60. PubMed ID: 23726431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIF-1α binding to AEG-1 promoter induced upregulated AEG-1 expression associated with metastasis in ovarian cancer.
    Zhao T; Zhao C; Zhou Y; Zheng J; Gao S; Lu Y
    Cancer Med; 2017 May; 6(5):1072-1081. PubMed ID: 28401704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-199a-5p is associated with hypoxia-inducible factor-1α expression in lungs from patients with COPD.
    Mizuno S; Bogaard HJ; Gomez-Arroyo J; Alhussaini A; Kraskauskas D; Cool CD; Voelkel NF
    Chest; 2012 Sep; 142(3):663-672. PubMed ID: 22383663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-433 Inhibits the Proliferation and Migration of HUVECs and Neurons by Targeting Hypoxia-Inducible Factor 1 Alpha.
    Zhang L; Zhang Y; Zhang X; Zhang Y; Jiang Y; Xiao X; Tan J; Yuan W; Liu Y
    J Mol Neurosci; 2017 Feb; 61(2):135-143. PubMed ID: 27815672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppressing miR-199a-3p by promoter methylation contributes to tumor aggressiveness and cisplatin resistance of ovarian cancer through promoting DDR1 expression.
    Deng Y; Zhao F; Hui L; Li X; Zhang D; Lin W; Chen Z; Ning Y
    J Ovarian Res; 2017 Jul; 10(1):50. PubMed ID: 28743276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced ROBO4 is mediated by up-regulation of HIF-1α/SP1 or reduction in miR-125b-5p/miR-146a-5p in diabetic retinopathy.
    Gong Q; Xie J; Li Y; Liu Y; Su G
    J Cell Mol Med; 2019 Jul; 23(7):4723-4737. PubMed ID: 31094072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-145 inhibits the growth, invasion, metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha.
    Zhang H; Pu J; Qi T; Qi M; Yang C; Li S; Huang K; Zheng L; Tong Q
    Oncogene; 2014 Jan; 33(3):387-97. PubMed ID: 23222716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.